In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a suglat Drug Master File in Korea (suglat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of suglat. The MFDS reviews the suglat KDMF as part of the drug registration process and uses the information provided in the suglat KDMF to evaluate the safety and efficacy of the drug.
After submitting a suglat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their suglat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of suglat suppliers with KDMF on PharmaCompass.